0

Category: Uncategorized

Insulin Biosimilars- A New Player in the Future of Diabetes Management

Partner Blog Series: American Society of Endocine Physician Assistants (ASEPA)

In working to further our mission to help clinicians stay up-to-date on the latest education within cardiometabolic health, we have partnered with ASEPA to present the following blog to highlight a new and valuable clinical option in the practice of diabetes management.

Diabetes is a chronic illness that affects approximately 30.3 million people or 9.4% of the US population, and is associated with increased morbidity, mortality, and healthcare costs. Read more

Maternal A1c Linked to Autism Risk in Children

Maternal diabetes, if not treated adequately, may increase the risk of several serious health complications in children. Epidemiologic data suggest that maternal pre-existing type 1, type 2, or gestational diabetes can influence the risk for autism spectrum disorders  (ASDs) in offspring. Hyperglycemia in utero increases uterine inflammation, oxidative stress, and hypoxia, potentially altering gene expression and disrupting fetal brain development, which increases the risk for neural behavior disorders. According to current estimates, 1 in 59 children is affected by autism and the prevalence of the disorder continues to rise steadily.  Read more